On the recordNovember 30, 2016
I congratulate Chairman Upton and all of our colleagues on the Energy and Commerce Committee for a job well done, and done in the appropriate manner. It really has, as Ms. DeGette said, been so interesting to work across the country and work with patients, with physicians, with researchers, with those who are innovating new concepts, who are delving into delivery systems that are necessary for precision medicine which underpins 21st century health care. There are three components that I want to bring attention to. First of all, section 3060 is there addressing medical technology and software. This is so important that we get the FDA on the right track and move components of this away so that it does not face FDA approval processes that will slow down access to the marketplace for patients. Also, section 2038, the Children's Count Act--Mrs. Capps and I worked on this--allowing children access to clinical trials, and section 3076, the reauthorization of the Reagan-Udall language. I congratulate my colleagues.
